Rigel Pharmaceuticals (RIGL) Tops Q3 Earnings and Revenue Estimates

Rigel Pharmaceuticals (RIGL) came out with quarterly earnings of $1.46 per share, beating the Zacks Consensus Estimate of $0.93 per share. This compares to earnings of $0.7 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +56.99%. A quarter ago, it was expected that this drug developer would post earnings of $1.97 per share when it actually produced earnings of $3.28, delivering a surprise of +66.5%.Over the last four quarters, ...